News

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.

U.S. News & World Report shares results of a new study finding heart disease has plagued humanity for centuries.

KMBC shared results of a new study led by Saint Luke's Mid America Heart Institute finding evidence of heart disease in ancient mummies.

Feeling “off” turned into a critical situation within moments when Stacee suffered a ruptured brain aneurysm that led to a hemorrhagic stroke.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.

Dr. Suzanne Arnold weighs in on new findings that may help explain how anger contributes to the risk of having a heart attack.

Consumer Reports On Health talked to Dr. Bethany Austin and Austin Workman about strategies to improve quality of life for those living with heart failure.

Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.